Canadian Journal of Gastroenterology (Jan 2010)

Efficacy and Safety of a Novel Pegylated Interferon Alpha-2a in Egyptian Patients with Genotype 4 Chronic Hepatitis C

Alaa Awad Taha,
Ahmad El-Ray,
Maged El-Ghannam,
Bahaa Mounir

Affiliations

Alaa Awad Taha: Department of Hepatogastroenterology, Theodor Bilharz Research Institute, Egypt
Ahmad El-Ray: Department of Hepatogastroenterology, Theodor Bilharz Research Institute, Egypt
Maged El-Ghannam: Department of Hepatogastroenterology, Theodor Bilharz Research Institute, Egypt
Bahaa Mounir: Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

DOI: https://doi.org/10.1155/2010/717845
Journal volume & issue: Vol. 24, no. 10
pp. 597 – 602

Abstract

BACKGROUND: Hepatitis C virus (HCV) genotype 4 is a common infection in Egypt and is the leading cause of liver disease.

Published in Canadian Journal of Gastroenterology

ISSN: 0835-7900 (Print); 1916-7237 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
Website: https://onlinelibrary.wiley.com/journal/1720

About the journal